Preferred Label : thienopyridine;

MeSH note : patients were treated with thienopyridine after percutaneous coronary intervention;

Is substance : O;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


http://www.pharmactuel.com/index.php/pharmactuel/article/view/1065/850
2016
false
false
false
false
Canada
French
drug administration schedule
critical appraisal or critical reading
Drug-Eluting stents
drug therapy, combination
multicenter studies as topic
thrombosis
aspirin
aspirin
Prasugrel Hydrochloride
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
thienopyridine
platelet aggregation inhibitors
Drug-eluting coronary stent placement
hemorrhage
Coronary stent thrombosis
thienopyridine
stroke
myocardial infarction
time
platelet aggregation inhibitors
pyridines
pyridines
Clopidogrel

---
Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.